| Long-Term Effects of COVID-19 | Lifetime | 163 | KR 4 | 98.34 |
| COVID-19 and Mental Health | Lifetime | 194 | KR 2 | 98.07 |
| COVID-19 Clinical Research Studies | Lifetime | 874 | KR 14 | 97.09 |
| Long-Term Effects of COVID-19 | 2021-2025 | 29 | KR 1 | 99.39 |
| COVID-19 and Mental Health | 2021-2025 | 52 | KR 1 | 99.10 |
| COVID-19 Clinical Research Studies | 2021-2025 | 306 | KR 4 | 98.51 |
| Heparin-Induced Thrombocytopenia and Thrombosis | 2021-2025 | 37 | KR 1 | 94.69 |
| COVID-19 and healthcare impacts | 2021-2025 | 588 | KR 5 | 92.15 |
| Pregnancy and Medication Impact | 2021-2025 | 109 | KR 2 | 93.76 |
| Asthma and respiratory diseases | 2021-2025 | 550 | KR 8 | 94.89 |
| Obesity, Physical Activity, Diet | 2021-2025 | 707 | KR 5 | 93.85 |
| Health disparities and outcomes | 2021-2025 | 710 | KR 12 | 91.86 |
| Herpesvirus Infections and Treatments | 2021-2025 | 258 | KR 2 | 89.83 |
| Dermatology and Skin Diseases | 2021-2025 | 681 | KR 25 | 90.27 |
| Intensive Care Unit Cognitive Disorders | 2021-2025 | 875 | KR 19 | 88.43 |
| Influenza Virus Research Studies | 2021-2025 | 626 | KR 19 | 88.61 |
| Allergic Rhinitis and Sensitization | 2021-2025 | 625 | KR 14 | 90.57 |
| Pharmacovigilance and Adverse Drug Reactions | 2021-2025 | 104 | KR 2 | 86.56 |
| Gastroesophageal reflux and treatments | 2021-2025 | 390 | KR 30 | 88.12 |
| Physical Activity and Health | 2021-2025 | 616 | KR 8 | 89.48 |
| Cardiovascular Health and Risk Factors | 2021-2025 | 431 | KR 5 | 85.71 |
| Drug-Induced Adverse Reactions | 2021-2025 | 273 | KR 9 | 84.96 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | 2021-2025 | 860 | KR 44 | 84.91 |
| Pediatric health and respiratory diseases | 2021-2025 | 442 | KR 27 | 80.80 |
| Suicide and Self-Harm Studies | 2021-2025 | 925 | KR 20 | 83.39 |
| Dermatological and COVID-19 studies | 2021-2025 | 181 | KR 1 | 76.54 |
| Nutrition, Health and Food Behavior | 2021-2025 | 172 | KR 125 | 76.23 |
| Platelet Disorders and Treatments | 2021-2025 | 974 | KR 9 | 78.45 |
| Facial Nerve Paralysis Treatment and Research | 2021-2025 | 463 | KR 49 | 73.62 |
| Optical Imaging and Spectroscopy Techniques | 2021-2025 | 888 | KR 23 | 73.57 |
| Rabies epidemiology and control | 2021-2025 | 708 | KR 4 | 68.38 |
| Poxvirus research and outbreaks | 2021-2025 | 829 | KR 5 | 67.02 |
| Health, psychology, and well-being | 2021-2025 | 849 | KR 4 | 65.66 |
| Hair Growth and Disorders | 2021-2025 | 658 | KR 54 | 67.45 |
| Health Promotion and Cardiovascular Prevention | 2021-2025 | 438 | KR 10 | 62.77 |
| Electroconvulsive Therapy Studies | 2021-2025 | 949 | KR 13 | 50.82 |
| Nephrotoxicity and Medicinal Plants | 2021-2025 | 303 | KR 12 | 33.58 |